[Postkala-azar dermal leishmaniasis].
de Juan Martín
F
F
Servicio de Infecciosos, Hospital Infantil Miguel Servet, Zaragoza.
Justa Roldán
M L
ML
Sáez de Adana Pérez
E
E
Navarro Serrano
E
E
Bouthelier Moreno
M
M
Gilaberte Calzada
Y
Y
Fortuño Cebamanos
B
B
D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D006801:Humans; D007893:Leishmania donovani / Q000302:isolation & purification*; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy / Q000469:parasitology*; D008297:Male; D008536:Meglumine / Q000008:administration & dosage / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate
Leishmaniasis dérmica postkala-azar.